Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07025408 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 17, 2025 (before its estimated March 18, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.
Trial Details
NCT Number NCT07025408
Lead Sponsor Shanghai Bao Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Burn, Burn Wounds - Partial Thickness (2nd Degree)
Related terms Burns
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov